Catherine Flores
ASO PROF
MD-NEUROLOGICAL SURGERY
GRANTS
- GRANTElucidating Tumor Cell CTGF-TGF-? Signaling Axis in driving Pancreatic Cancer CachexiaNational Institute of Health Nci10 Jun 2026 - 15 Aug 2029
- GRANTNext-generation mRNA vaccine for glioblastomaIoncologi31 Mar 2026 - 31 Mar 2027
- GRANTOvercoming Immune Checkpoint Blockade Resistance in Glioblastoma with a Novel Stem Cell BiotherapeuticNational Institute of Health Nci13 Mar 2026 - 31 Aug 2026
- GRANTDevelopmentally regulated antigens to target pediatric gliomaFlorida Department of Health13 Jul 2025 - 31 Dec 2026
- GRANTThe role of adoptive cellular therapy on myeloid-derived suppressor cell depletion in gliomaNational Institute of Health Nci10 Jul 2025 - 16 Aug 2029
- GRANTThe Florida Summer Training in Research and Oncology for the Next Generation of Researchers (STRONGER) ProgramNational Institute of Health Nci24 Jun 2025 - 31 May 2030
- GRANTThe Sunshine Project: Understanding Major Immunological Mechanisms That Allow Therapy to Overcome Treatment Resistance in Refractory Pediatric TumorsNational Pediatric Cancer Foundation12 Apr 2025 - 30 Jun 2026
- GRANTCHAMP1ON - Combinatorial Hematopoietic Stem Cell And Monoclonal Antibody PD-1 Blockade Phase 1 "Window of Opportunity" Trial for RecurreNt Pediatric High-Grade GliomaFlorida Department of Health Live Like Bella11 Jan 2024 - 31 May 2028
- GRANTDevelopmentally regulated antigens for immunologic targeting of pediatric brain tumorsNational Institute of Health Ninds6 Jul 2023 - 31 Jul 2025
- GRANTImmunotherapy for Synucleinopathies: Can Gut Microbiota Affect Efficacy?National Institute of Health Ninds12 Jun 2023 - 31 May 2026
- GRANTSRB Thank you - FloresAlexs Lemonade Stand Foundation28 Dec 2021 - 26 Sep 2022
- GRANTUnderstanding Major Immunological Mechanisms That Allow Therapy to Overcome Treatment Resistance in Refractory Pediatric TumorsNational Pediatric Cancer Foundation17 Nov 2021 - 30 Jun 2023
- GRANTF30 (Francis) Thymic PD-1 blockade mediates the anti-tumor immune response in pediatric high-grade gliomaNational Institute of Health Nci5 May 2021 - 15 May 2026
- GRANTA consortium effort to translate therapies for neurological diseases via an immune-competent organotypic platformNational Institute of Health Ncats17 Feb 2021 - 30 Apr 2025
- GRANTHematopoietic stem cells overcome treatment resistance to PD-1 blockade against brain tumorsNational Institute of Health Ninds10 Sep 2020 - 30 Jun 2025
- GRANTAdoptive Cell Therapies and Translational Neuroimaging in Synucleinopathy: Implications for Dementia with Lewy Body and Parkinson's DiseaseNational Institute of Health Ninds23 Sep 2019 - 31 Aug 2022
- GRANTThe use of hematopoietic stem and progenitor cells to reverse treatment resistance to PD-1 blockadeAlexs Lemonade Stand Foundation20 Sep 2019 - 31 Mar 2021
- GRANTHematopoietic stem cells overcome treatment resistance to adoptive cellular therapy against malignant gliomasNational Institute of Health Ninds20 Aug 2019 - 30 Jun 2024
- GRANTEngineering T cell metabolic fitness to treat pediatric brain tumors20 Jun 2019 - 30 Mar 2021
- GRANTEnhancing efficacy of adoptive immunotherapy against DIPG using hematopoietic stem cellsMultiple Sponsors1 Jan 2018 - 31 Dec 2019
- GRANTEvaluating the use of hematopoietic stem cells in overcoming immunosuppression within the brain tumor microenvironmentAmerican Brain Tumor Association13 Jun 2017 - 1 Oct 2019
- GRANTPediatric Oncology Student Training (POST) ProgramAlexs Lemonade Stand Foundation25 Apr 2017 - 31 Aug 2017
- GRANTFlores - ALFS Equipment AwardAlexs Lemonade Stand Foundation17 Apr 2017 - 31 May 2018
- GRANTNovel role of hematopoietic stem cells in immunologic rejection of malignant pediatric brain tumorsAlexs Lemonade Stand Foundation22 Jun 2015 - 30 Sep 2020